These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38915710)

  • 21. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model.
    Yadav PD; Mohandas S; Shete AM; Nyayanit DA; Gupta N; Patil DY; Sapkal GN; Potdar V; Kadam M; Kumar A; Kumar S; Suryavanshi D; Mote CS; Abraham P; Panda S; Bhargava B
    Vector Borne Zoonotic Dis; 2022 May; 22(5):289-296. PubMed ID: 35580212
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduction in SARS-CoV-2 Virus Infectivity in Human and Hamster Feces.
    Wurtzer S; Lacote S; Murri S; Marianneau P; Monchatre-Leroy E; Boni M; Ferraris O; Maday Y; Kébé O; Dia N; Peyrefitte C; Sokol H; Obepine Consortium ; Moulin L; Maréchal V
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.
    Selvaraj P; Lien CZ; Liu S; Stauft CB; Nunez IA; Hernandez M; Nimako E; Ortega MA; Starost MF; Dennis JU; Wang TT
    Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for the spread of SARS-CoV-2 and olfactory cell lineage impairment in close-contact infection Syrian hamster models.
    Ueha R; Ito T; Ueha S; Furukawa R; Kitabatake M; Ouji-Sageshima N; Uranaka T; Tanaka H; Nishijima H; Kondo K; Yamasoba T
    Front Cell Infect Microbiol; 2022; 12():1019723. PubMed ID: 36339331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters.
    Brocato RL; Principe LM; Kim RK; Zeng X; Williams JA; Liu Y; Li R; Smith JM; Golden JW; Gangemi D; Youssef S; Wang Z; Glanville J; Hooper JW
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32900822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine.
    Xu J; Liu M; Niu X; Hanson J; Jung K; Ru P; Tu H; Jones DM; Vlasova AN; Saif LJ; Wang Q
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persimmon-derived tannin has antiviral effects and reduces the severity of infection and transmission of SARS-CoV-2 in a Syrian hamster model.
    Furukawa R; Kitabatake M; Ouji-Sageshima N; Suzuki Y; Nakano A; Matsumura Y; Nakano R; Kasahara K; Kubo K; Kayano SI; Yano H; Ito T
    Sci Rep; 2021 Dec; 11(1):23695. PubMed ID: 34880383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
    J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectious SARS-CoV-2 Is Emitted in Aerosol Particles.
    Hawks SA; Prussin AJ; Kuchinsky SC; Pan J; Marr LC; Duggal NK
    mBio; 2021 Oct; 12(5):e0252721. PubMed ID: 34663099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.
    Yen HL; Sit THC; Brackman CJ; Chuk SSY; Gu H; Tam KWS; Law PYT; Leung GM; Peiris M; Poon LLM;
    Lancet; 2022 Mar; 399(10329):1070-1078. PubMed ID: 35279259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.
    van der Lubbe JEM; Rosendahl Huber SK; Vijayan A; Dekking L; van Huizen E; Vreugdenhil J; Choi Y; Baert MRM; Feddes-de Boer K; Izquierdo Gil A; van Heerden M; Dalebout TJ; Myeni SK; Kikkert M; Snijder EJ; de Waal L; Stittelaar KJ; Tolboom JTBM; Serroyen J; Muchene L; van der Fits L; Rutten L; Langedijk JPM; Barouch DH; Schuitemaker H; Zahn RC; Wegmann F
    NPJ Vaccines; 2021 Mar; 6(1):39. PubMed ID: 33741993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model.
    Li C; Chen YX; Liu FF; Lee AC; Zhao Y; Ye ZH; Cai JP; Chu H; Zhang RQ; Chan KH; Chiu KH; Lung DC; Sridhar S; Hung IF; To KK; Zhang AJ; Chan JF; Yuen KY
    Clin Infect Dis; 2021 Aug; 73(3):e719-e734. PubMed ID: 33515458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious droplet exposure is an inefficient route for SARS-CoV-2 infection in the ferret model.
    James J; Byrne AMP; Goharriz H; Golding M; Cuesta JMA; Mollett BC; Shipley R; M McElhinney L; Fooks AR; Brookes SM
    J Gen Virol; 2022 Nov; 103(11):. PubMed ID: 36748502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.
    Patel DR; Field CJ; Septer KM; Sim DG; Jones MJ; Heinly TA; Vanderford TH; McGraw EA; Sutton TC
    J Virol; 2021 Jun; 95(13):e0223220. PubMed ID: 33827954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model.
    Patel DR; Minns AM; Sim DG; Field CJ; Kerr AE; Heinly TA; Luley EH; Rossi RM; Bator CM; Moustafa IM; Norton EB; Hafenstein SL; Lindner SE; Sutton TC
    Microbiol Spectr; 2024 Mar; 12(3):e0499822. PubMed ID: 38334387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing contributions of airborne route in SARS-CoV-2 omicron variant transmission compared with the ancestral strain.
    Ji S; Xiao S; Wang H; Lei H
    Build Environ; 2022 Aug; 221():109328. PubMed ID: 35784591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection.
    Nuñez IA; Lien CZ; Selvaraj P; Stauft CB; Liu S; Starost MF; Wang TT
    mSphere; 2021 Jun; 6(3):e0050721. PubMed ID: 34133199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.
    Chan JF; Zhang AJ; Yuan S; Poon VK; Chan CC; Lee AC; Chan WM; Fan Z; Tsoi HW; Wen L; Liang R; Cao J; Chen Y; Tang K; Luo C; Cai JP; Kok KH; Chu H; Chan KH; Sridhar S; Chen Z; Chen H; To KK; Yuen KY
    Clin Infect Dis; 2020 Dec; 71(9):2428-2446. PubMed ID: 32215622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters.
    Neary M; Sharp J; Gallardo-Toledo E; Herriott J; Kijak E; Bramwell C; Cox H; Tatham L; Box H; Curley P; Arshad U; Rajoli RKR; Pertinez H; Valentijn A; Dhaliwal K; Mc Caughan F; Hobson J; Rannard S; Kipar A; Stewart JP; Owen A
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract.
    Hansen F; Meade-White K; Clancy C; Rosenke R; Okumura A; Hawman DW; Feldmann F; Kaza B; Jarvis MA; Rosenke K; Feldmann H
    Cell Rep; 2022 Mar; 38(11):110515. PubMed ID: 35263638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.